Evidence map›Paper›PMID 42572228›Full record

ArticleJournal of gastroenterology and hepatology2026

BEAT-B Study (Behavior, Aspirations, and Treatment Needs): A Mixed-Methods Study of Patient Values, Preferences, and Barriers to Care Among People Living With Chronic Hepatitis B in South and Southeast Asia.

Manya Prasad, Tushar Prabhakar, Priyanka Shenoy, Priyanka Aggarwal, Tawesak Tanwandee, K C Sudhamshu, M Golam Azam, Zaigham Abbas, G Vaishnavi, Vivekanandan Shanmugam and 2 more

Abstract read
In one paragraph

Article in Journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Manya PrasadInstitute of Liver and Biliary Sciences, New Delhi, India.
Tushar PrabhakarInstitute of Liver and Biliary Sciences, New Delhi, India.ORCID https://orcid.org/0000-0002-6559-6867
Priyanka ShenoyInstitute of Liver and Biliary Sciences, New Delhi, India.
Priyanka AggarwalInstitute of Liver and Biliary Sciences, New Delhi, India.
Tawesak TanwandeeSiriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0001-7634-0843
K C SudhamshuNational Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
M Golam AzamBIRDEM Academy, Dhaka, Bangladesh.ORCID https://orcid.org/0000-0001-6357-451X
Zaigham AbbasZiauddin University Hospital, Karachi, Pakistan.
G VaishnaviChennai Liver Foundation, Chennai, India.
Vivekanandan ShanmugamChennai Liver Foundation, Chennai, India.
Bharat Bhushan RewariInstitute of Liver and Biliary Sciences, New Delhi, India.
Shiv Kumar SarinInstitute of Liver and Biliary Sciences, New Delhi, India.ORCID https://orcid.org/0000-0002-0544-5610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic hepatitis B (HBV) infections have significant challenges in treatment uptake and adherence due to sociocultural barriers, healthcare system inefficiencies, and economic constraints. The evidence to decision framework highlights the importance of understanding patient values and preferences to align evidence-based policies with the "treat all" approach.

methodsThis mixed-methods study included a cross-sectional survey in five South Asian countries and qualitative data collection through focus group discussions and interviews. Qualitative data explored patient perceptions, barriers, and facilitators in the care continuum, employing thematic analysis. Quantitative data analyzed demographic, socioeconomic, and clinical determinants of treatment uptake and adherence.

findingsQualitative analysis identified key themes, such as the psychological burden of living with HBV, the aspiration for treatment to protect loved ones, and the critical role of clear guidance and social support in facilitating care. Quantitative findings revealed that higher education levels (OR: 2.0; 95% CI: 1.3-3.1), family support (OR: 1.9; 95% CI: 1.3-2.8), and urban residence (OR: 1.7; 95% CI: 1.1-2.5) were significant predictors of treatment uptake. A significant gap in the knowledge and understanding of the chronic nature of HBV among patients, with only 20.5% recognizing it as a long-term condition and need for family counseling, was noted.

interpretationThese findings highlight the importance of incorporating patient values and lived experiences into HBV care models and policy development. Simplified care pathways, strengthened counseling, enhanced family engagement, and improved affordability may help address barriers to treatment uptake and retention in care.

Indexed as

Health Services AccessibilityHepatitis B, ChronicPatient PreferenceAdultAsia, SoutheasternAsia, SouthernCross-Sectional StudiesFamily SupportFemaleHumansMaleMiddle AgedQualitative ResearchSocial SupportSocioeconomic Factorscare pathwayshealth seeking behaviorhepatitis Bquality of lifestigma

Identifiers

PMID42572228
PMCPMC13534291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.